The largest database of trusted experimental protocols

Gammacell 3000

Manufactured by Best Theratronics
Sourced in Canada

The Gammacell 3000 is a self-shielded gamma irradiator designed for research and medical applications. It utilizes a Cobalt-60 source to generate gamma radiation. The Gammacell 3000 provides a uniform dose distribution within the irradiation chamber, which can accommodate a variety of sample sizes.

Automatically generated - may contain errors

6 protocols using gammacell 3000

1

Growth Curve Analysis of Radiation-Treated Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
For growth curve analysis, cells expressing H2B-GFP were treated with 0, 2, 6 or 8 Gy of radiation in a Gammacell 3000 (Best Theratronics) and seeded in a 96-well plate. Cell proliferation was followed using the IncuCyte ZOOM or IncuCyte S3 Live-cell Imaging System (Sartorius, Göttingen, Germany) using a 10× objective. The number of cells was evaluated using Incucyte® Software by the number of green fluorescent nucleus of cells expressing H2B-GFP in at least two wells per condition. Experiments were performed at least three times.
+ Open protocol
+ Expand
2

T Cell Proliferation Assay with Staphylococcal Antigens

Check if the same lab product or an alternative is used in the 5 most similar protocols
Anonymized buffy coats were obtained from healthy blood donors at the Irish Blood Transfusion Service, Dublin, Ireland. Peripheral blood mononuclear cells (PBMCs) were isolated, and CD4+ cells were purified (CD4+ T cell isolation kit; Miltenyi Biotec) and labeled with carboxyfluorescein diacetate succinimidyl ester (CFSE) as previously described (5 (link)). PBMCs were gamma irradiated at 30 Gy with a 137Cs source (Gammacell 3000 Best Theratronics). CFSE-labeled CD4+ cells (1 × 105) were cocultured with irradiated PBMCs (APCs) (1 × 105) with cRPMI alone (negative control), staphylococcal enterotoxin A (100 ng/ml [positive control]), heat-inactivated S. aureus (1 μg/ml ≈ 1 × 107 CFU/ml), or purified staphylococcal antigens (0.88 μM). cRPMI comprised RPMI (Sigma), 10% (vol/vol) fetal calf serum (Biosera), 100 mM l-glutamine (Gibco), and 100 μg/ml penicillin-streptomycin (Gibco). T cell proliferation and cytokine production were assessed on day 10 by flow cytometry.
+ Open protocol
+ Expand
3

Clonogenic Assay for Irradiated OSCC Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
OSCC cells were seeded at a density of 200,000 cells per dish in 60-mm dishes and cultured overnight before pretreatment with 10 µM LPA for one hour prior to irradiation. In experiments using inhibitors, cells were pretreated with 10 µM LPA for one hour prior to the addition of 10 µM NS-398 for a further one hour before irradiation. Media were changed prior to irradiating the cells with 0-8 gray (Gy) gamma using the Gammacell 3000 (Best Theratronics, Ottawa, Canada). Irradiated cells were harvested immediately by trypsinisation. Cells were counted and 300-500 cells were plated in triplicate for clonogenic survival assays. The cells were incubated for 12 days with media changed every four days and colonies stained with 0.1% (w/v) crystal violet. Colonies with >50 cells were counted as one colony. The plating efficiency (PE) and survival fraction (SF) were calculated using the following equations: PE=number of colonies formednumber of cells seeded×100%
SF=PE after irradiationPE of control×100%
+ Open protocol
+ Expand
4

Ionizing Radiation and Targeted Therapies

Check if the same lab product or an alternative is used in the 5 most similar protocols
Ionizing radiation treatment was performed with the Gammacell 3000 (Best Theratronics, Ottawa, ON, Canada) at defined doses (0, 2, 4, 6, 8 or 10 Gy). We purchased ABT-199 (Venetoclax) that inhibited BCL2 or ABT-263 (Navitoclax) for BCL2/BCLxl/BclW from Medchem and APExBIO. Both drugs were prepared with Dimethyl sulfoxide (DMSO) and DMSO from Sigma was used for vehicle alone in control condition. In combination treatment, pre-irradiation conditions represented cells that were exposed to 8 Gy of radiation five days before adding drugs while control cells were seeded two to three days before drug addition.
+ Open protocol
+ Expand
5

Gamma Irradiation of 3D Spheroids

Check if the same lab product or an alternative is used in the 5 most similar protocols
Two days after seeding, fresh media were added to each channel before irradiation of spheroids directly on chip using the Gammacell 3000 irradiator (Best Theratronics, Ottawa, ON, Canada) at defined doses (0, 2, 4 and 8 Gy).
+ Open protocol
+ Expand
6

Leukoreduced and Irradiated RBC Transfusion

Check if the same lab product or an alternative is used in the 5 most similar protocols
RBCs were collected in bags containing citrate-phosphate-dextrose-adenine-1. Prior to transfusion, RBCs underwent post-storage leukoreduction using an RCM1 filter (Haemonetics, Braintree, MA) until March 2012, and thereafter RBCs underwent pre-storage leukoreduction using an RC2VAE filter (Haemonetics). Both filters reduce the number of residual leukocytes per RBC unit to <210 5 . All RBCs were further gamma-irradiated using our on-site cesium-137 irradiators: an IBL 437 (CIS, Bedford, MA) was used until February 2008, and thereafter, a GammaCell 3000 was used (Best Theratronics, Ottawa, Ontario, Canada). The irradiation duration was modified based on dose distribution mapping performed by outside experts so that the absorbed-dose at the center of the target was 25 Gy, with a minimum of >15 Gy and maximum of <50 Gy throughout the target (Supplementary Fig. S1). The use of RBCs stored for >24 hours after irradiation was prohibited because of concerns of massive RBC storage lesion (e.g. hyperkalemia) without the consideration of plasma washing. 23 Compatibility was routinely evaluated using ABO/Rh typing, testing recipient serum for clinically important alloantibodies, and serologically cross-matching donor RBCs with recipient serum. Our blood bank delivered RBCs to the operating room using the first-in-first-out principle to consume older RBCs before newer one. 6
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!